Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.
Grebien F, Hantschel O, Wojcik J, Kaupe I, Kovacic B, Wyrzucki AM, Gish GD, Cerny-Reiterer S, Koide A, Beug H, Pawson T, Valent P, Koide S, Superti-Furga G.
Grebien F, et al. Among authors: valent p.
Cell. 2011 Oct 14;147(2):306-19. doi: 10.1016/j.cell.2011.08.046.
Cell. 2011.
PMID: 22000011
Free PMC article.